期刊文献+

芍药苷对APP/PS1小鼠的神经细胞保护作用及机制研究 被引量:10

Protective effect of paeoniflorin on nerve cells in APP/PS1 mice and its mechanism
下载PDF
导出
摘要 目的:探讨芍药苷(paeoniflorin,PF)通过抑制细胞凋亡通路而产生神经细胞保护作用的机制。方法:分别选用15只5月龄雄性APP/PS1非显性小鼠作为正常对照组,15只5月龄雄性APP/PS1双转基因小鼠为模型组和15只5月龄雄性APP/PS1双转基因小鼠为给药组(5 mg/kg的PF腹腔注射)。采用水迷宫实验检测各组小鼠的学习和记忆能力。采用TUNEL荧光染色法检测脑内神经细胞凋亡情况。采用Western Blot检测脑内皮层及海马区PI3K、Akt、p-PI3K、p-Akt、caspase-3、caspase-9、Bcl-2和Bax的蛋白表达水平,并用免疫组化分析caspase-3和caspase-9的蛋白表达水平及分布情况。结果:(1)与正常对照组相比,APP/PS1模型组小鼠的学习和记忆能力明显下降;与APP/PS1模型组相比,PF明显改善小鼠的学习和记忆能力。(2)与正常对照组相比,APP/PS1模型组小鼠脑内神经细胞凋亡明显增多,分布区域较广,而PF给药组小鼠凋亡细胞明显减少。(3)与APP/PS1模型组相比,PF给药组能显著下调促凋亡因子caspase-3、caspase-9和Bax的表达水平(P<0.05),同时上调抑凋亡因子pPI3K、p-Akt和Bcl-2的表达水平(P<0.05)。结论:PF可能通过激活PI3K/Akt通路而上调Bcl-2,下调caspase-9、caspase-3和Bax的蛋白表达水平,从而抑制神经细胞凋亡和保护神经细胞,以治疗神经退行性疾病。 AIM: To investigate the therapeutic and preventive effects of paeoniflorin( PF) on APP/PS1 mice,and to explore the possible mechanism. METHODS: Fifteen male 5-month-old APP/PS1 non-dominant mice were chosen as normal control group,15 male 5-month-old APP/PS1 double transgenic mice were used as model group,and 15 male 5-month-old APP/PS1 double transgenic mice treated with 5 mg/kg PF by intraperitoneal injection were allocated in administation group. The learning and memory ability of the mice in each group was detected by Morris water maze. The apoptosis was assessed by TUNEL fluorescence staining. The protein expression of PI3K,Akt,p-PI3K,p-Akt,caspase-3,caspase-9,Bcl-2 and Bax in cerebral cortex and hippocampus was detected by Western Blot. The protein expression levels and distribution of caspase-3 and caspase-9 were detected by immunohistochemistry. RESULTS:( 1) Compared with normal control group,the learning and memory ability declined in APP/PS1 model group. Compared with APP/PS1 model group,PF obviously improve the ability of learning and memory in mice.( 2) Compared with normal control group,the apoptosis of nerve cells in APP/PS1 model group significantly increased and distributed in wider areas,while that in PF group was reduced( P〈0. 05).( 3) Compared with APP/PS1 model group,PF could significantly lower pro-apoptotic factors,caspase-3,caspase-9 and Bax( P〈0. 05),and increase the expression of anti-apoptotic factors,p-PI3K,p-Akt and Bcl-2( P〈0. 05). CONCLUSION: PF can up-regulate the expression of Bcl-2 and down-regulate the expression levels of caspase-9,caspase-3 and Bax via the activation of PI3K/Akt pathway,thereby inhibiting the nerve cell apoptosis and protecting the nerve cells,so as to treat neurodegenerative diseases.
作者 曾嘉豪 杨承佑 文军 张茂营 王向宇 ZENG Jia-hao;YANG Cheng-you;WEN Jun;ZHANG Mao-ying;WANG Xiang-yu(Jinan University,Department of Neurosurgery,The first Affiliated Hospital of Jinan University,Guangzhou 510632,China)
机构地区 暨南大学
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2018年第6期1049-1054,共6页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.81500915) 广东省自然科学基金资助项目(No.A2016570)
关键词 芍药苷 APP/PS1小鼠 细胞凋亡 神经细胞 PI3K/AKT信号通路 Paeoniflorin APP/PS1 mice Apoptosis Nerve cells PI3K/Akt signaling pathway
  • 相关文献

参考文献2

二级参考文献67

  • 1康春生,浦佩玉,李捷,王广秀.反义及显性负调节AKT2 RNA对脑胶质瘤细胞增殖抑制作用的体外研究[J].癌症,2004,23(11):1267-1272. 被引量:5
  • 2王宏梅,陈龙华,郑小康,李启生,伍新尧,夏云飞.抑制ATM/PI3K功能区表达对鼻咽癌细胞CNE1辐射增敏的研究[J].癌症,2006,25(9):1097-1101. 被引量:9
  • 3Atkins M B, Hidalgo M, Stadler W M, et al. Randomized phase Ⅱ study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma [J]. J Clin Oncol, 2004, 22(5) :909-918.
  • 4Christian T, James R, Zoran F, et al. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer : implications for therapy [ J ]. Proc Natl Acad Sci USA, 2006,103 (6) : 1888-1893.
  • 5Adachi S, Leoni L M, Carson D A, et al. Apoptosis induced by molecular targeting therapy in hematological malignancies [J]. Acta Haematol, 2004,111(1-2) : 107-123.
  • 6Campiglio M, Olgiati C, Normanno N, et al. Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 ( 'Iressa' ) is independent of EGFR expression level [J]. J Cell Physiol, 2004,198(2): 259-268.
  • 7Zhang M, Fang X, Liu H, et al. Blockade of AKT activation in prostate cancer cells with a small molecule inhibitor, 9-chIoro-2-methylellipticinium acetate (CMEP) [J]. Biochem Pharmacol, 2007,73( 1 ) : 15-24.
  • 8Douglas A L, Faina B, Cindy J Y, et al. Frequent mutation of the P1K3CA gene in ovarian and breast cancer [J]. Clin Cancer Res, 2005,11 (8):2875- 2878.
  • 9Knobbe C B, Kieslich A T, Reifenberger G. Genetic alteration and expression of the phosphoinositol-3- kinase/Akt pathway genes P1K3CA and PIKE in human glioblastomas [J]. Neuropathol Appl Neurobiol, 2005, 31 (5) :486-490.
  • 10Oda K, Stokoe D, Taketani Y, et al. High frequency of coexistent mutations of P1K3CA and PTEN genes in endometrial carcinoma [ R ]. Cancer Res, 2005,65(23) : 10669-10673.

共引文献138

同被引文献187

引证文献10

二级引证文献232

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部